Академический Документы
Профессиональный Документы
Культура Документы
Jun Tao
Stroke and Ischemic Heart Disease (IHD) Mortality Rate in Each Decade of Age, Versus Usual Systolic BP at the Start of that Decade
Stroke
Age at risk 8089 y 256 128 64 7079 y 6069 y 5059 y 256 128 64 32 16 4049 y 8 4 2 1
IHD
Age at risk 8089 y 7079 y 6069 y 5059 y
Mortality*
32
16 8 4
2
1
0 120
140
160
180
120
140
160
180
Introduction
Primary hypertension is a clinical syndrome characterized by the increase in systemic arterial pressure.
95% 0f the patients with hypertension are primary hypertension with unknown causes and 5% secondary hypertension with definitive causes.
Hypertension affects approximately 1 billion individual worldwide. In China the incidence of hypertension is about 180 million individuals.
Primary hypertension
The pathogenesis of primary hypertension is still unclear. There are many factors associate with it.
Genetic factors Sodium intake Renin agiotensin systems Sympathetic nervous system Endothelial dysfunction Insulin resistance Other factors
Genetic factors The offsprings of the hypertensive parents are prone to suffering from essential hypertension compared with that without hypertensive family.
Sodium intake The mechanisms leading to hypertension are due to increased blood volume and the content of the sodium in the smooth muscle cells enhance following subsequent calcium increase.
RAAS system
ReninAngiotensinogen Angiotensin I
Sympathetic nervous activation The activation of Sympathetic nervous can augment periphery resistant which increase systemic arterial pressure.
Endothelial dysfunction Endothelium-derived vasodilating factors: NO; PGI2; EDHF. Endothelial-derived vasoconstricting factors:ET; AGII; Superoxide anion.
Insulin resistance Increased absorbability to sodium Increased sympathetic nervous activation Increased cellular contents in sodium and calcium Caused vascular wall hypertrophy
Other factors Obesity Smoking Intake alcohol OSAS Low calcium , magnesium and potassium.
Pathology
Systemic atherosclerosis develops with increased intimal-medium thickness leading to ischemic alterations in target organs such as heart, brain, kidney and peripheral artery.
Aorta and large arteries recurrent pulsatile stress produces uncoiling, disruption and calcification of elasstic fibres. At the same time, relatively inelastic collagen is increased.
This is a result of ageing as well as hypertension : both processes therefore cause loss of the normal elastic reservoir funtion of the aorta and large arteries.
This explains one curious feature of elderly hypertensive patients. Diastolic blood pressure in patients with isolated systolic hypertension is inversely related to prognosis.
Medium-sized arteries The predominant pathological change is wall thickening caused by increased deposition of collagenous material.
Resistance vessel The characteristic structural change in smaller arteries and arterioles responsible for peripheral vascular resistance is an increase in wall:lumen ratio.
In recent years it has become clear that what was thought to be a trophic response is largely if not entirely due to rearrangement of smooth muscle cells around a smaller lumen.
The heart Angina and myocardial infarction in the hypertensive patient are usually due to coronary atheroma.
Left ventricular hypertrophy is demonstrable in about 50 per cent of untreated hypertensive patients when echocardiography is used, and in 5 to 10 per cent with electrocardiography using conventional criteria.
Central nervous system Cerebral infarction in a hypertensive patient is usually attributable to atheroma of one of the larger cerebral arteries (usually the middle cerebral artery) and accounts for about 80 percent of the strokes which these patients suffer.
Intracerebral haemorrhage accounts for 10 to 15 percent, usually the result of rupture of a small intracerebral degenerative microaneurysm.
The kidney The long-term renal damage produced by glomerular hypertension probably accountd for progressive glomerulosclerosis in essential hypertension.
Atheromatous renal vascular disease much more commonly causes renal impairment in elderly hypertensive subjects than younger patients with treated mild to moderate hypertension.
Retinopathy Keith-Wagener classification Stage I: constriction of retinal arterioles only. Stage II: constriction and sclerosis of retinal arterioles. Stage III: hemorrhages and exudates in addition to vascular changes. Stages IV: papilledema.
Symptoms
Headache the classic hypertensive headache is present on walking in the morning, situated in the occipital region of the head, radiating to the frontal area, throbbing in quality, and wears off during the course of the day.
Most headaches in hypertensive patients are tension headaches not directly related to blood pressure. Nevertheless, effective treatment of hypertension reduces the incidence of headache.
Epistaxis Whilst epistaxis is not associated with mild hypertension, it is much more common in moderate to severe hypertension.
Nocturia this is one of the most frequent clinically apparent consequences of blood pressure elevation resulting from reduction in urineconcentrating capacity.
Cardiovascular system Effort dyspnoea and orthopnoea suggest cardiac failure. Increased left ventricular mass is associated with decreased compliance and impaired cardiac output response to exercise.
Central nervous system Extensive disease of the perforating arteries may give rise to a lacunar state characterized by progressive pseudobulbar plasy and dementia.
Renal system Haematuria suggest the malignant phase of hypertension in the absence of any other cause.
Retinopathy Scotomas suggest fundal haemorrhages or exudates, whilst blurring of vision is associated with papilloedema.
Complications
Hypertensive emergencies Hypertensive encephalopathy Cerebrovascular disease Heart failure Chronic kidney disease Dissection of aorta
physical examination
SBP>=140 mmHg or DBP>=90 mmHg. Loud aortic second sound Other physical signs indicate target organ damage
Diagnosis
Diagnosis of primary hypertension depends on repeatedly demonstrating higher than-normal systolic and /or diastolic BP and excluding secondary hypertension.
Category
Optimal blood pressure Normal blood pressure High-normal blood pressure Grade 1 Hypertension (mild) Grade 2 Hypertension (moderate) Grade 3 Hypertension (severe) Isolated Systolic Hypertension (Grade 1) Isolated Systolic Hypertension (Grade 2)
Family history of premature CVD (men under age 55 or women under age 65)
*Components of the metabolic syndrome.
Grade 1(SBP 140159 or DBP 9099) No other risk factors 12 risk factors
3 or more risk factors or diabetes or target organ damage
Low-risk Moderaterisk
Medium-risk
Very High-risk
High-risk
High-risk
Very High-risk
complications
Very Highrisk
Very High-risk
Very High-risk
Laboratory examinations
Serum potassium, creatine, blood glucose, blood lipids, complete blood count, uric acid, ECG, cardiac and chest x-ray exam and funduscopic exam for retinopathy. ABPM Double peaks and one hollow
Goals of Therapy
Reduce CVD and renal morbidity and mortality.
Treat to BP <140/90 mmHg or BP <130/80 mmHg in patients with diabetes or chronic kidney disease. Achieve SBP goal especially in persons >50 years of age.
Meta-analysis
Blood Pressure Reduction of 2 mmHg Decreases the Risk of Cardiovascular Events by 710%
risk of ischaemic heart disease mortality 10% reduction in risk of stroke mortality
Lifestyle Modification
Weight reduction: the trial of hypertension prevention produced an average weight loss of 3.8 kg at 18 months, reduction of SBP and DBP by 2.9 and 2.3 mm Hg.
Exercise: Following increased physical activity, BP falls up 6-7 mm Hg for both SBP and DBP.
Sodium restriction Alcohol reduction and smoking cessation Stress reduction/relaxing training Dietary changes: low salt intake; potassium, magnesium and calcium supplementation; others.
Stage 1 Hypertension
(SBP 140159 or DBP 9099 mmHg) Thiazide-type diuretics for most. May consider ACEI, ARB, BB, CCB, or combination.
Stage 2 Hypertension
(SBP >160 or DBP >100 mmHg) 2-drug combination for most (usually thiazide-type diuretic and ACEI, or ARB, or BB, or CCB)
Not at Goal Blood Pressure Optimize dosages or add additional drugs until goal blood pressure is achieved. Consider consultation with hypertension specialist.
Drug treatment
Diuretics -Blockers Calcium channel blockers ACE inhibitors Angiotensin II receptor blockers -Adrenergic blockers
Blockers Indications :angina after myocardial infarction tachyarrhythmias cardiac failure (with care) Contraindications :asthma and chronic obstructive airway disease peripheral vascular disease
Calcium antagonists: Indications :systolic hypertension in the elderly Contraindications:heart block (verapamil and diltiazem)
ACEI Indications: cardiac failure left ventricular dysfunction after myocardiac infarction (higherrisk patients) diabetic nephropathy and other proteinuric renal disease Contraindications: pregnancy renovascular disease sodium and fluid depletion hyperkalaemia
ARB Indications: as for ACEI in presence of ACEI induced cough or intolerance Contraindications: as for ACEI
Compelling and possible indications, contraindications, and cautions for the major classes of antihypertensive drugs
Class of drug Alphablockers Compelling indications Benign prostatic hypertrophy Chronic renal disease, Type II diabetic nephropathy, proteinuric renal disease LV dysfunction post MI, intolerance of other antihypertensive drugs, proteinuric renal disease, chronic renal disease, heart failure Possible indications Compelling contraindications Urinary incontinence Pregnancy, renovascular disease
ACEHeart failure, inhibitors LV dysfunction, post MI or established CVD, Type I diabetic nephropathy, 2o stroke prevention ARBs ACE inhibitorintolerance, Type II diabetic nephropathy, hypertension with LVH, heart failure in ACEintolerant patients, post MI
Compelling and possible indications, contraindications, and cautions for the major classes of antihypertensive drugs
Class of drug Beta-blockers Compelling indications MI, Angina Possible indications Heart failure Caution Heart failure, PVD, Diabetes (except with CHD) Combination with betablockade Compelling contraindications Asthma/COPD, Heart block
Angina Elderly
Normal
Prehypertension
<120
and <80
Encourage
Yes
120139 or 8089
Stage 1 Hypertension
Stage 2 Hypertension
140159 or 9099
Yes
>160
or >100
Yes
Thiazide-type diuretics for most. Drug(s) for the May consider ACEI, ARB, BB, compelling indications. CCB, or combination. Other antihypertensive Two-drug combination for most drugs (diuretics, ACEI, (usually thiazide-type diuretic ARB, BB, CCB) as and ACEI or ARB or BB or needed. CCB).
*Treatment determined by highest BP category. Initial combined therapy should be used cautiously in those at risk for orthostatic hypotension. Treat patients with chronic kidney disease or diabetes to BP goal of <130/80 mmHg.
Primary prevention
(1) Aspirin: use 75mg daily if patient is aged 50 years with blood pressure controlled to <150/90 mm Hg and either; target organ damage, diabetes mellitus, or 10 year risk of cardiovascular disease of 20% (measured by using the new Joint British Societies cardiovascular disease risk chart) (2) Statin: use sufficient doses to reach targets if patient is aged up to at least 80 years, with a 10 year risk of cardiovascular disease of 20% (measured by using the new Joint British Societies cardiovascular disease risk chart) and with total cholesterol concentration 3.5mmol/l (3) Vitaminsno benefit shown, do not prescribe
Lipid targets
Targets for lipid lowering Ideal TC<4.0mmol/l or LDL <2.0mmol/l or 25% in TC or 30% in LDL-C whichever is the greater TC <5.0mmol/l or LDL <3.0mmol/l or 25% in TC or 30% in LDL-C whichever is the greater
Audit
Goals of treatment
-BP < 140/90 mmHg in all hypertensive patients < 130/80 mmHg in hypertensive patients with diabetes or renal disease
2.
3. 4. 5. 6. 7. 8.
Renal parenchymal disease Renovascular hypertension Phaeochromocytoma Primary aldosteronism Cushingsyndrome Obstructive sleep apnoea Coarctation of aorta Drug-induced hypertension